1. Home
  2. NVNI vs VNRX Comparison

NVNI vs VNRX Comparison

Compare NVNI & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nvni Group Limited

NVNI

Nvni Group Limited

HOLD

Current Price

$3.65

Market Cap

57.2M

Sector

N/A

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.28

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVNI
VNRX
Founded
2019
N/A
Country
Brazil
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.2M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NVNI
VNRX
Price
$3.65
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.17
AVG Volume (30 Days)
165.7K
2.7M
Earning Date
09-30-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,250,627.00
$1,472,007.00
Revenue This Year
$12.05
$55.33
Revenue Next Year
$15.02
$493.79
P/E Ratio
N/A
N/A
Revenue Growth
1491.58
14.48
52 Week Low
$1.44
$0.27
52 Week High
$121.90
$0.94

Technical Indicators

Market Signals
Indicator
NVNI
VNRX
Relative Strength Index (RSI) 59.53 34.91
Support Level $3.32 $0.28
Resistance Level $3.00 $0.31
Average True Range (ATR) 0.32 0.03
MACD 0.07 0.00
Stochastic Oscillator 65.07 17.50

Price Performance

Historical Comparison
NVNI
VNRX

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: